Abstract
Purpose of Review
Brucellosis is a neglected, zoonotic disease of nearly worldwide distribution. Despite brucellosis being recognized as a reproductive disease in animals, it has been historically known as a flu-like illness in humans with little or no significant role in maternal or newborn health. This review focuses on what is currently known relative to the epidemiology of brucellosis in human pregnancy as well as new insights of placental immunology.
Recent Findings
New evidence suggests that maternal infection poses a significant risk factor for adverse pregnancy outcomes including increased risk for miscarriage during the first and second trimester of gestation, preterm delivery, and vertical transmission to the fetus. Adverse pregnancy outcomes were not associated with any specific clinical sign. However, prompt diagnosis and treatment significantly decreased the risk of miscarriage or any other adverse effect.
Summary
Brucellosis during pregnancy should be considered a significant risk factor for adverse pregnancy outcomes in humans. The identification of the mechanism behind bacterial tropism should prove powerful for the development of new countermeasures to prevent these detrimental effects. Increased awareness concerning brucellosis in pregnant women, its transmission, and prevention measures should be considered as a pressing need.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Moreno E. Retrospective and prospective perspectives on zoonotic brucellosis. Front Microbiol. 2014;5:213. doi:10.3389/fmicb.2014.00213.
Olsen SC, Palmer MV. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 2014;51(6):1076–89. doi:10.1177/0300985814540545.
Wanke MM. Canine brucellosis. Anim Reprod Sci. 2004;82–83:195–207. doi:10.1016/j.anireprosci.2004.05.005.
Johnson B, Mosier DA, Morton RJ, Confer AW. Experimental Brucella abortus strain 19 arthritis in young cattle. J Vet Diagn Investig. 1994;6(1):56–61.
Coid CR, Vaughan LC. Incidence of carpal hygromas in dairy cattle infected with Br. abortus and maintained in an isolation compound. J Comp Pathol. 1957;67(1):53–6.
Pappas G, Papadimitriou P. Challenges in Brucella bacteraemia. Int J Antimicrob Agents. 2007;30 Suppl 1:S29–31. doi:10.1016/j.ijantimicag.2007.06.011.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325–36. doi:10.1056/NEJMra050570.
Schlabritz-Loutsevitch NE, Whatmore AM, Quance CR, Koylass MS, Cummins LB, Dick Jr EJ, et al. A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J Med Primatol. 2009;38(1):70–3. doi:10.1111/j.1600-0684.2008.00314.x.
Wernery U. Camelid brucellosis: a review. Rev Sci Tech. 2014;33(3):839–57.
Dagleish MP, Barley J, Finlayson J, Reid RJ, Foster G. Brucella ceti associated pathology in the testicle of a harbour porpoise (Phocoena phocoena). J Comp Pathol. 2008;139(1):54–9. doi:10.1016/j.jcpa.2008.03.004.
Guzman-Verri C, Gonzalez-Barrientos R, Hernandez-Mora G, Morales JA, Baquero-Calvo E, Chaves-Olarte E, et al. Brucella ceti and brucellosis in cetaceans. Front Cell Infect Microbiol. 2012;2:3. doi:10.3389/fcimb.2012.00003.
Thorne ET, Morton JK. Brucellosis in elk. II. Clinical effects and means of transmission as determined through artificial infections. J Wildl Dis. 1978;14(3):280–91.
Williams E. Brucellosis in humans: its diagnosis and treatment. APMIS. 1988;3:21–5.
Welburn SC, Beange I, Ducrotoy MJ, Okello AL. The neglected zoonoses—the case for integrated control and advocacy. Clin Microbiol Infect. 2015;21(5):433–43. doi:10.1016/j.cmi.2015.04.011.
Eyre J. Melitensis septicemia. Lancet. 1908:1747–52.
Mohammad KI, El Ghazaly MM, Zaalouk TK, Morsy AT. Maternal brucellosis and human pregnancy. J Egypt Soc Parasitol. 2011;41(2):485–96.
Karcaaltincaba D, Sencan I, Kandemir O, Guvendag-Guven ES, Yalvac S. Does brucellosis in human pregnancy increase abortion risk? Presentation of two cases and review of literature. J Obstet Gynaecol Res. 2010;36(2):418–23. doi:10.1111/j.1447-0756.2009.01156.x.
Schreyer P, Caspi E, Leiba Y, Eshchar Y, Sompolinsky D. Brucella septicemia in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1980;10(2):99–107.
Al-Tawfiq JA, Memish ZA. Pregnancy associated brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8(1):47–50.
Figueroa Damian R, Rojas Rodriguez L, Marcano Tochon ES. Brucellosis in pregnancy: course and perinatal results. Ginecol Obstet Mex. 1995;63:190–5.
Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001;32(8):1172–7. doi:10.1086/319758. This is an interesting review article were they characterized 92 pregnant women with acute brucellosis and adverse pregnancy outcomes.
Vilchez G, Espinoza M, D’Onadio G, Saona P, Gotuzzo E. Brucellosis in pregnancy: clinical aspects and obstetric outcomes. Int J Infect Dis. 2015;38:95–100. doi:10.1016/j.ijid.2015.06.027.
Cacace ML, Claros EA, Erazu KA, Escobar GI, Lucero NE. Congenital brucellosis in an infant. Vector Borne Zoonotic Dis. 2013;13(7):513–5. doi:10.1089/vbz.2012.1165.
Peker N, Turan V, Ergenoglu M, Yeniel O. Brucellosis in adolescent pregnancy—case report and review of literature. Ginekol Pol. 2011;82(3):226–9.
Elshamy M, Ahmed AI. The effects of maternal brucellosis on pregnancy outcome. J Infect Dev Ctries. 2008;2(3):230–4.
Fernihough TJ, Munoz WP, Mahadeyo I. The role of Brucella abortus in spontaneous abortion among the black population. S Afr Med J. 1985;68(6):379–80.
Kurdoglu M, Adali E, Kurdoglu Z, Karahocagil MK, Kolusari A, Yildizhan R, et al. Brucellosis in pregnancy: a 6-year clinical analysis. Arch Gynecol Obstet. 2010;281(2):201–6. doi:10.1007/s00404-009-1106-0.
Malone FD, Athanassiou A, Nores LA, Dalton ME. Poor perinatal outcome associated with maternal Brucella abortus infection. Obstet Gynecol. 1997;90(4 Pt 2):674–6.
Aydin B, Beken S, Akansel R, Dilli D, Okumus N, Zenciroglu A, et al. Prematurity due to maternal brucella infection and review of the literature. Turk J Pediatr. 2013;55(4):433–7.
Lubani MM, Dudin KI, Sharda DC, Abu Sinna NM, Al-Shab T, Al-Refe’ai AA, et al. Neonatal brucellosis. Eur J Pediatr. 1988;147(5):520–2.
Roushan MR, Baiani M, Asnafi N, Saedi F. Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran. Trans R Soc Trop Med Hyg. 2011;105(9):540–2. doi:10.1016/j.trstmh.2011.06.003.
Gulsun S, Aslan S, Satici O, Gul T. Brucellosis in pregnancy. Trop Dr. 2011;41(2):82–4. doi:10.1258/td.2011.100386.
Ceylan A, Kostu M, Tuncer O, Peker E, Kirimi E. Neonatal brucellosis and breast milk. Indian J Pediatr. 2012;79(3):389–91. doi:10.1007/s12098-011-0581-z.
Porreco RP, Haverkamp AD. Brucellosis in pregnancy. Obstet Gynecol. 1974;44(4):597–602.
Poole PM, Whitehouse DB, Gilchrist MM. A case of abortion consequent upon infection with Brucella abortus biotype 2. J Clin Pathol. 1972;25(10):882–4.
Seoud M, Saade G, Awar G, Uwaydah M. Brucellosis in pregnancy. J Reprod Med. 1991;36(6):441–5.
Veznik Z. Brucellosis in gynecology and obstetrics. Lek List. 1954;9(23):548–9.
Criscuolo E, Di Carlo FC. Abortion and other gynecological and obstetrical disorders in brucellosis. Rev Fac Cienc Med Cordoba. 1954;12(3):321–30.
Schachter M. Congenital diseases in infants due to melitococcal infections in pregnancy. Acta Pediatr Esp. 1954;12(138):521–4.
Chheda S, Lopez SM, Sanderson EP. Congenital brucellosis in a premature infant. Pediatr Infect Dis J. 1997;16(1):81–3.
Rujeni N, Mbanzamihigo L. Prevalence of Brucellosis among women presenting with abortion/stillbirth in Huye. Rwanda J Trop Med. 2014;2014:740479. doi:10.1155/2014/740479.
Madkour MM. Pregnancy and Brucellosis. In: Madkour MM, editor. Madkour, s Brucellosis. 2nd ed. New York: Springer; 2001. p. 197–202.
Makhseed M, Harouny A, Araj G, Moussa MA, Sharma P. Obstetric and gynecologic implication of brucellosis in Kuwait. J Perinatol. 1998;18(3):196–9.
Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, Fenech FF. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med. 1988;66(249):39–54.
Sarram M, Feiz J, Foruzandeh M, Gazanfarpour P. Intrauterine fetal infection with Brucella melitensis as a possible cause of second-trimester abortion. Am J Obstet Gynecol. 1974;119(5):657–60.
Fallatah SM, Oduloju AJ, Al-Dusari SN, Fakunle YM. Human brucellosis in Northern Saudi Arabia. Saudi Med J. 2005;26(10):1562–6.
Hackmon R, Bar-David J, Bashiri A, Mazor M. Brucellosis in pregnancy. Harefuah. 1998;135(1–2):3–7. 88.
Young EJ. Human brucellosis. Rev Infect Dis. 1983;5(5):821–42.
Janbon M, de Kerleau C. Brucellose humanie et avortment: Isolement de Brucella melitensis dans le sangde la mere, les visceras, et le sang du foetus, le placenta, et les lochies. Presse Med. 1939;47:453.
Cornell EL, DeYoung CR. The incidence of undulant fever in pregnancy and abortion. Am J Obstet Gynecol. 1929;18:840–4.
Poester FP, Samartino LE, Santos RL. Pathogenesis and pathobiology of brucellosis in livestock. Rev Sci Tech. 2013;32(1):105–15.
Gladstone M, Oliver C, Van den Broek N. Survival, morbidity, growth and developmental delay for babies born preterm in low and middle income countries - a systematic review of outcomes measured. PLoS One. 2015;10(3), e0120566. doi:10.1371/journal.pone.0120566.
Carmichael LE, Shin SJ. Canine brucellosis: a diagnostician’s dilemma. Semin Vet Med Surg (Small Anim). 1996;11(3):161–5.
Carmichael LE, George LW. Canine brucellosis: newer knowledge. Dev Biol Stand. 1976;31:237–50.
Carmichael LE, Kenney RM. Canine brucellosis: the clinical disease, pathogenesis, and immune response. J Am Vet Med Assoc. 1970;156(12):1726–34.
Racicot K, Kwon JY, Aldo P, Silasi M, Mor G. Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol. 2014;72(2):107–16. doi:10.1111/aji.12289.
PrabhuDas M, Bonney E, Caron K, Dey S, Erlebacher A, Fazleabas A, et al. Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol. 2015;16(4):328–34. doi:10.1038/ni.3131.
Cao B, Stout MJ, Lee I, Mysorekar IU. Placental microbiome and its role in preterm birth. Neoreviews. 2014;15(12):e537–45. doi:10.1542/neo.15-12-e537.
Witkin SS, Linhares IM, Bongiovanni AM, Herway C, Skupski D. Unique alterations in infection-induced immune activation during pregnancy. BJOG. 2011;118(2):145–53. doi:10.1111/j.1471-0528.2010.02773.x.
Kwak-Kim JY, Gilman-Sachs A, Kim CE. T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy. 2005;88:64–79. doi:10.1159/000087821.
Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol. 2002;48(2):77–86.
Krishnan L, Nguyen T, McComb S. From mice to women: the conundrum of immunity to infection during pregnancy. J Reprod Immunol. 2013;97(1):62–73. doi:10.1016/j.jri.2012.10.015.
Furukawa S, Kuroda Y, Sugiyama A. A comparison of the histological structure of the placenta in experimental animals. J Toxicol Pathol. 2014;27(1):11–8. doi:10.1293/tox.2013-0060.
Cantle SJ, Kaufmann P, Luckhardt M, Schweikhart G. Interpretation of syncytial sprouts and bridges in the human placenta. Placenta. 1987;8(3):221–34.
Koga K, Mor G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol. 2010;63(6):587–600. doi:10.1111/j.1600-0897.2010.00848.x.
Manaster I, Mandelboim O. The unique properties of uterine NK cells. Am J Reprod Immunol. 2010;63(6):434–44. doi:10.1111/j.1600-0897.2009.00794.x.
Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014;124(5):1872–9. doi:10.1172/JCI68107.
Tilburgs T, Crespo AC, van der Zwan A, Rybalov B, Raj T, Stranger B, et al. Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes. Proc Natl Acad Sci U S A. 2015;112(23):7219–24. doi:10.1073/pnas.1507977112.
Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies. Am J Reprod Immunol. 2010;63(6):460–71. doi:10.1111/j.1600-0897.2010.00813.x.
Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22(1):116–33. doi:10.1093/humupd/dmv041.
Smith H, Williams AE, Pearce JH, Keppie J, Harris-Smith PW, Fitz-George RB, et al. Foetal erythritol: a cause of the localization of Brucella abortus in bovine contagious abortion. Nature. 1962;193:47–9.
Sangari FJ, Grillo MJ, Jimenez De Bagues MP, Gonzalez-Carrero MI, Garcia-Lobo JM, Blasco JM, et al. The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice. Vaccine. 1998;16(17):1640–5.
Bosseray N. Brucella infection and immunity in placenta. Ann Inst Pasteur Microbiol. 1987;138(1):110–3.
Anderson TD, Cheville NF, Meador VP. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. II. Ultrastructural studies. Vet Pathol. 1986;23(3):227–39.
Anderson TD, Meador VP, Cheville NF. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. I. Gross and histologic lesions. Vet Pathol. 1986;23(3):219–26.
Salcedo SP, Chevrier N, Lacerda TL, Ben Amara A, Gerart S, Gorvel VA, et al. Pathogenic brucellae replicate in human trophoblasts. J Infect Dis. 2013;207(7):1075–83. doi:10.1093/infdis/jit007. First report describing the mechanism of Brucella infection in human trophoblast.
Fernandez AG, Ferrero MC, Hielpos MS, Fossati CA, Baldi PC. Proinflammatory Response of Human Trophoblastic Cells to Brucella abortus Infection and upon Interactions with Infected Phagocytes. Biol Reprod. 2016;94(2):48. doi:10.1095/biolreprod.115.131706. This article nicely decribed pathophisiology of pregnancy complications in brucellosis using human trophoblastic cell line (Swan 71).
Olsen SC, Johnson C. Comparison of abortion and infection after experimental challenge of pregnant bison and cattle with Brucella abortus strain 2308. Clin Vaccine Immunol. 2011;18(12):2075–8. doi:10.1128/CVI.05383-11.
Davis DS, Templeton JW, Ficht TA, Huber JD, Angus RD, Adams LG. Brucella abortus in Bison. II. Evaluation of strain 19 vaccination of pregnant cows. J Wildl Dis. 1991;27(2):258–64. doi:10.7589/0090-3558-27.2.258.
Dawood HA. Brucellosis in Camels (Camelus dromedorius) in the south province of Jordan. Am J Agric Biol Sci. 2008;3:623–6.
Megid J, Mathias LA, Robles CA. Clinical manifestations of brucellosis in domestic animals and humans. Open Vet Sci J. 2010;4:119–26.
Carmichael LE, Kenney RM. Canine abortion caused by Brucella canis. J Am Vet Med Assoc. 1968;152(6):605–16.
Barkallah M, Gharbi Y, Hassena AB, Slima AB, Mallek Z, Gautier M, et al. Survey of infectious etiologies of bovine abortion during mid- to late gestation in dairy herds. PLoS One. 2014;9(3), e91549. doi:10.1371/journal.pone.0091549.
Carvalho Neta AV, Mol JP, Xavier MN, Paixao TA, Lage AP, Santos RL. Pathogenesis of bovine brucellosis. Vet J. 2010;184(2):146–55. doi:10.1016/j.tvjl.2009.04.010.
Samartino LE, Enright FM. Pathogenesis of abortion of bovine brucellosis. Comp Immunol Microbiol Infect Dis. 1993;16(2):95–101.
Miller WG, Adams LG, Ficht TA, Cheville NF, Payeur JP, Harley DR, et al. Brucella-induced abortions and infection in bottlenose dolphins (Tursiops truncatus). J Zoo Wildl Med. 1999;30(1):100–10.
Kreeger TJ, Cook WE, Edwards WH, Elzer PH, Olsen SC. Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion. J Wildl Dis. 2002;38(1):27–31. doi:10.7589/0090-3558-38.1.27.
Kreeger TJ, Miller MW, Wild MA, Elzer PH, Olsen SC. Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk. J Wildl Dis. 2000;36(3):477–83. doi:10.7589/0090-3558-36.3.477.
Edmonds MD, Cloeckaert A, Hagius SD, Samartino LE, Fulton WT, Walker JV, et al. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant. Res Vet Sci. 2002;72(3):235–9. doi:10.1053/rvsc.2002.0555.
Elzer PH, Enright FM, McQuiston JR, Boyle SM, Schurig GG. Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res Vet Sci. 1998;64(3):259–60.
Phillips RW, Elzer PH, Robertson GT, Hagius SD, Walker JV, Fatemi MB, et al. A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion. Res Vet Sci. 1997;63(2):165–7.
Zundel E, Verger JM, Grayon M, Michel R. Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serological responses. Ann Rech Vet. 1992;23(2):177–88.
Gidlewski T, Cheville NF, Rhyan JC, Miller LD, Gilsdorf MJ. Experimental Brucella abortus induced abortion in a llama: pathologic effects. Vet Pathol. 2000;37(1):77–82.
Perez-Sancho M, Duran-Ferrer M, Garcia-Seco T, Macias P, Garcia N, Martinez I, et al. Interferon-gamma responses in sheep exposed to virulent and attenuated Brucella melitensis strains. Vet Immunol Immunopathol. 2014;160(1–2):123–8. doi:10.1016/j.vetimm.2014.03.014.
Duran-Ferrer M, Leon L, Nielsen K, Caporale V, Mendoza J, Osuna A, et al. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis. Vet Microbiol. 2004;100(3–4):219–31. doi:10.1016/j.vetmic.2004.02.008.
Verger JM, Grayon M, Zundel E, Lechopier P, Olivier-Bernardin V. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Vaccine. 1995;13(2):191–6.
OIE. Porcine Brucellosis. OIE Terrestrial Manual, 2012.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the National Institutes of Health (NIH), International Research Scientist Development Award-IRSDA/K01 (grant number 1K01 TW009981-01).
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Rights and permissions
About this article
Cite this article
Arenas-Gamboa, A.M., Rossetti, C.A., Chaki, S.P. et al. Human Brucellosis and Adverse Pregnancy Outcomes. Curr Trop Med Rep 3, 164–172 (2016). https://doi.org/10.1007/s40475-016-0092-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-016-0092-0